MASLD versus MAFLD in lean steatotic liver disease: diagnostic overlap, inclusivity, and the metabolically healthy lean phenotype

Maha Elsabaawy, Heba Demerdash, Amr Ragab, Madiha Naguib · 2025

Read MASLD versus MAFLD in lean steatotic liver disease: diagnostic overlap, inclusivity, and the metabolically healthy lean phenotype by Maha Elsabaawy, Heba Demerdash, Amr Ragab, Madiha Naguib (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12769525.txt.

Description

Thin people get fatty liver too, and two rival naming systems compete to describe them. Maha Elsabaawy and co-authors rechecked ninety lean Egyptian patients with ultrasound-confirmed fatty liver against both frameworks: MAFLD, the older label, and MASLD, its newer replacement. Nearly 88 percent met the MASLD bar and 78 percent the MAFLD bar, with heavy overlap. Blood tests, metabolic measures, and liver stiffness readings looked much the same under either flag, though the older label clung tighter to obvious metabolic trouble.

About one patient in eight fit neither system: lean, fatty livered, yet metabolically healthy. The authors argue the definitions need refining so this group stops falling through the crack between them.

Catalog record

CREATORMaha Elsabaawy, Heba Demerdash, Amr Ragab, Madiha Naguib
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE29 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC12769525

Browse the full library · About the Tower of Babel